Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16398 studies found for:    ( NOT NOTEXT ) [FIRST-RECEIVED-RESULTS-DATE]
Show Display Options
Rank Status Study
21 Completed
Has Results
A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination
Condition: Influenza
Intervention: Biological: Split, Inactivated, Trivalent Influenza vaccine (Fluzone®)
22 Completed
Has Results
Improving Smoking Cessation Outcomes in Heavy Drinkers - 1
Condition: Tobacco Use Disorder
Interventions: Behavioral: Standard treatment plus brief alcohol intervention;   Other: Standard treatment (ST)
23 Completed
Has Results
Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB
Condition: Hepatitis B Virus
Interventions: Drug: Telbivudine;   Drug: Tenofovir;   Drug: Telbivudine plus tenofovir
24 Completed
Has Results
A Study for the Treatment of Diabetic Peripheral Neuropathic Pain
Condition: Diabetic Neuropathies
Interventions: Drug: Duloxetine hydrochloride - 40 mg;   Drug: placebo;   Drug: Duloxetine hydrochloride - 60 mg
25 Completed
Has Results
Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls
Condition: Infections, Papillomavirus
Intervention: Biological: GSK Biologicals' HPV vaccine 580299
26 Completed
Has Results
BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours
Condition: Neoplasms
Interventions: Drug: BIBW 2992 low dose;   Drug: BIBW 2992 high dose;   Drug: pemetrexed;   Drug: BIBW 2992 high dose 6 day;   Drug: BIBW 2992 low dose 6 day;   Drug: BIBW 2992 medium dose 6 day;   Drug: BIBW 2992 medium dose
27 Completed
Has Results
Assessment of Long-Term Infliximab for Psoriasis (P05319)
Condition: Psoriasis
Intervention: Biological: Infliximab
28 Completed
Has Results
Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)
Condition: Insomnia
Intervention: Drug: Org 50081
29 Terminated
Has Results
GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
Conditions: Breast Cancer;   Neoplasm Metastasis
Interventions: Drug: Vorinostat;   Drug: Lapatinib
30 Completed
Has Results
Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women
Conditions: HIV Infections;   Sexually Transmitted Infections
Interventions: Behavioral: Healthy Love Workshop;   Behavioral: HIV/AIDS 101 Workshop
31 Completed
Has Results
Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Granulocyte-colony stimulating factor (G-CSF);   Drug: Fixed Dose Plerixafor;   Drug: Weight-Based Plerixafor
32 Completed
Has Results
Evaluation of DIDGET TM World Reports
Condition: Diabetes
Intervention: Device: DIDGET World Web Community Reports
33 Completed
Has Results
High-dose Bevacizumab in Advanced Renal Carcinoma Patients
Conditions: Renal Cancer;   Kidney Cancer
Intervention: Drug: Bevacizumab
34 Completed
Has Results
Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine
Conditions: Meningitis;   Meningococcal Infection
Intervention: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®
35 Completed
Has Results
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cancer Of The Extrahepatic Bile Duct;   Ampullary Carcinoma
Interventions: Drug: ZD6474, Vandetanib;   Drug: Gemcitabine;   Drug: Placebo matching ZD6474
36 Completed
Has Results
Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Comparator: Rosiglitazone;   Drug: Comparator: Placebo;   Drug: Comparator: Metformin
37 Completed
Has Results
Efficacy of Pregabalin in Patients With Radicular Pain
Conditions: Neuropathy; Radicular, Lumbar, Lumbosacral;   Failed Back Surgery Syndrome;   Spinal Stenosis;   Herniated Disc
Interventions: Drug: Pregabalin;   Drug: Sugar Pill
38 Completed
Has Results
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
Condition: Melanoma
Interventions: Drug: Glycoprotein 100 (GP100): 209-217 (210M);   Drug: Interleukin-2 (IL-2);   Drug: Montanide ISA 51;   Drug: Melanoma antigen recognized by T-cells (MART)-1: 27-35;   Drug: 27-35 (27L): melanoma antigen recognized by T-cells (MART)-1;   Drug: melanoma antigen recognized by T-cells (MART)-1: 26-35(27L)
39 Terminated
Has Results
Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim
Condition: Severe Combined Immunodeficiency
Interventions: Drug: Transplant Conditioning with Mobilization Only;   Drug: Transplant Conditioning with Mobilization and Alemtuzumab
40 Completed
Has Results
A Crossover Study on the Blinding Effect of a New Pragmatic Placebo Needle
Condition: Device Ineffective
Interventions: Device: real needle-  placebo needle;   Device: placebo needle - real needle

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years